Hi, I am Ajay Nooka, My LiveDNA is 91.283
Dr. Ajay Nooka
Highest Degree: M.D. in Internal Medicine from Northeastern Ohio Universities Colleges of Medicine, USA
Institute: Emory University, USA
Area of Interest: Biomedical Sciences
  •   Cancer
  •   Clinical Oncology
  •   Chemotherapy
  •   Molecular Carcinogenesis
URL: http://livedna.org/91.283
My SELECTED Publications
1:   Gleason, C., A. Nooka and S. Lonial, 2009. Supportive therapies in multiple myeloma. J. Natl. Comp. Cancer Network, 7: 971-979.
PubMed  |  Direct Link  |  
2:   Hoff, A.O., B.B Toth, K. Altundag, M.M. Johnson and C.L. Warneke et al., 2008. Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J. Bone Mineral Res., 23: 826-836.
CrossRef  |  PubMed  |  Direct Link  |  
3:   Lin, E.H., M. Hassan, Y. Li, H. Zhao and A. Nooka et al., 2007. Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence. Cancer, 110: 534-542.
CrossRef  |  PubMed  |  Direct Link  |  
4:   Nooka, A., J. Kaufman and S. Lonial, 2009. The importance of complete response in outcomes in myeloma. Cancer J., 15: 465-472.
CrossRef  |  PubMed  |  Direct Link  |  
5:   Patt, Y.Z., M.M. Hassan, A. Aguayo, A..K. Nooka and R.D. Lozano et al., 2004. Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma and gallbladder carcinoma. Cancer, 101: 578-586.
CrossRef  |  PubMed  |  Direct Link  |  
6:   Patt, Y.Z., M.M. Hassan, R.D. Lozano, A.K. Nooka and I.I. Schnirer et al., 2005. Thalidomide in the treatment of patients with hepatocellular carcinoma: A phase II trial. Cancer, 103: 749-755.
CrossRef  |  PubMed  |  Direct Link  |  
7:   Picolos, M.K., A. Nooka, A.B. Davis, B. Raval and P.R. Orlander, 2007. Bilateral adrenal hemorrhage: An overlooked cause of hypotension. J. Emergency Med., 32: 167-169.
CrossRef  |  PubMed  |  Direct Link  |  
8:   Shaib, Y.H., H.B. El-Serag, A. Nooka, M. Thomas, T.D. Brown, Y.Z. Patt and M.M. Hassan, 2007. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A hospital-based case-control study. Am. J. Gastroenterol., 102: 1016-1021.
CrossRef  |  PubMed  |  Direct Link  |